我国药物经济学评价的应用和前景分析:一项基于网络调查的研究OA北大核心CSTPCD

Objective To investigate and analyze the current situation and future perspectives of pharmacoeconomic evaluation in health care sector of China.Methods A structured questionnaire was created based on literature review and expert survey,covering the application and prospect of pharmacoeconomic evaluation in marketing research and development,listing,pricing,medical insurance,hospital,commercial insurance and other fields,as well as the needs and career development of professionals from different employers.Questionnaire survey was conducted in a WeChat group of relevant practitioners on condition of voluntary anonymity,and the results were statistically analyzed.Results The application and prospect of pharmacoeconomic evaluation in the pricing,access and adjustment of medical insurance has received the highest score(with 5 being the full score,the application level,importance and future prospect in the medical insurance pricing and access have received scores of 3.96,4.17 and 4.45 respectively,adjustment has received scores of 3.29,3.52 and 4.01 respectively).The scores in the stages of marketing research and development and hospital selection are average,and the scores in the rational clinical use and commercial insurance access are the lowest.Correspondingly,the demand of professionals is relatively high in professional consultation and pharmaceutical enterprises(with the scores of 3.56 and 3.39 respectively),good in professional consultation and scientific research institutes(with the score of 3.90),and not optimistic in medical institutions,commercial and insurance institutions.Conclusions The current application and development of pharmacoeconomic evaluation in China is centered on medical insurance pricing and access,and insufficient in hospitals and commercial insurance.And its development potentials need to be further explored.